TransMed, Willowglade Partner to Improve IOBS System for Value-Based Care

01/08/18

The new partnership between TransMed and Willowglade will provide help for the Innovative Oncology Business Solutions (IOBS) Triage Pathway to improve clinical decision support technology and alternative payment model reporting.

TransMed Systems—an oncology based health care technology, informatics, and clinical trial company—has entered into a partnership with Willowglade Technologies Corporation – a provider of the Patient Involvement Platform and surrounding solutions for clinical care and patient education. The goal of this new partnership is to replace the Allscripts-acquired technology that supports the IOBS Triage System and the IOBS Triage Pathways for step-by-step clinical decision-making.

This solution will support the National Cancer Care Alliance’s Diagnostic and Therapeutic Pathways.

“Partnering with TransMed and Willowglade, both leading technology providers to community oncology practices, will bring strategic technology to IOBS and will aid in accelerating the expansion of our Triage System and Triage Pathways to leading community oncology practices nationwide in support of their value-based care success,” said Barbara L McAneny, MD, CEO and CMO, IOBS, in a press release (January 8, 2018).

Oncology practices that use the IOBS Triage Pathway allow nurse navigators to assess calls from patients needing care. The Triage Pathways System offers evidence-based decision support to allow nurses to address patients concerns and navigate patients to optimal care.

-----

Related Content

Pharmacogenetic Testing and Clinical Decision Support Tools Improve Quality of Life, Reduce Costs

Development and Implementation of De Novo Clinical Decision Support Rules at a Tertiary Cancer Center

-----

“By improving the timeliness and coordination of care, while also reducing cost through avoidance of unnecessary ED and inpatient hospital visits, IOBS will be better able to enhance patient outcomes,” added Dr McAneny. “That mission is becoming increasingly important as oncology practices participating in the OCM or future APMs need interventions such as our triage pathways to directly reduce costs for which they are held accountable.”

The new TransMed Systems infrastructure with Willowglade will be available for deployment in early 2018.

"We think that having a stable platform that allows us to use the Triage Pathways with multiple different EMRs will expand their utility for more practices," Dr McAneny told Journal of Clinical Pathways.Zachary Bessette